Bibliografía

Referencias consultadas en la investigación del proyecto

Las 207 entradas reunidas durante las siete ramas de investigación. El archivo fuente está en docs/referencias/bibliografia.bib.

AdvertenciaVerificar antes de citar

Varias entradas corresponden a fuentes que no se pudieron leer completas: el campo note de cada una lo indica. Donde no se pudo confirmar un volumen, rango de páginas o DOI desde una fuente efectivamente abierta, el campo se omitió en vez de reconstruirlo.

Antes de que cualquiera de estas referencias entre al documento final, hay que verificar su DOI contra doi.org y leer la fuente.

Referencias

Abbott, N. J., Patabendige, A. A. K., Dolman, D. E. M., Yusof, S. R., & Begley, D. J. (2010). Structure and function of the blood-brain barrier. Neurobiology of Disease, 37(1), 13-25. https://doi.org/10.1016/j.nbd.2009.07.030

Ahmad, W., Simon, E., Chithrananda, S., Grand, G., & Ramsundar, B. (2022). ChemBERTa-2: Towards Chemical Foundation Models. arXiv preprint arXiv:2209.01712. https://doi.org/10.48550/arXiv.2209.01712

Baell, J. B., & Holloway, G. A. (2010). New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. Journal of Medicinal Chemistry, 53(7), 2719-2740. https://doi.org/10.1021/jm901137j

Baell, J. B., & Nissink, J. W. M. (2018). Seven year itch: pan-assay interference compounds (PAINS) in 2017—utility and limitations. ACS Chemical Biology, 13(1), 36-44. https://doi.org/10.1021/acschembio.7b00903

Bajorath, J. (2017). Molecular Similarity Concepts for Informatics Applications. En Methods in Molecular Biology (Vol. 1526, pp. 231-245). https://doi.org/10.1007/978-1-4939-6613-4_13

Bartus, R. T., Dean, R. L., Beer, B., & Lippa, A. S. (1982). The cholinergic hypothesis of geriatric memory dysfunction. Science, 217(4558), 408-414. https://doi.org/10.1126/science.7046051

Bemis, G. W., & Murcko, M. A. (1996). The Properties of Known Drugs. 1. Molecular Frameworks. Journal of Medicinal Chemistry, 39(15), 2887-2893. https://doi.org/10.1021/jm9602928

BIDD Group. (s. f.-a). CMAUP: A Database of Collective Molecular Activities of Useful Plants. http://bidd.group/CMAUP/.

BIDD Group. (s. f.-b). NPASS: Natural Product Activity and Species Source Database. http://bidd.group/NPASS/.

Bisson, J., McAlpine, J. B., Friesen, J. B., Chen, S.-N., Graham, J., & Pauli, G. F. (2016). Can Invalid Bioactives Undermine Natural Product-Based Drug Discovery? Journal of Medicinal Chemistry, 59(5), 1671-1690. https://doi.org/10.1021/acs.jmedchem.5b01009

Blevins, A. D., & Quigley, I. K. (2025). Clever Hans in Chemistry: Chemist Style Signals Confound Activity Prediction on Public Benchmarks. https://arxiv.org/abs/2512.20924

Butt, A. M., Jones, H. C., & Abbott, N. J. (1990). Electrical resistance across the blood-brain barrier in anaesthetized rats: a developmental study. The Journal of Physiology, 429, 47-62.

Capuzzi, S. J., Muratov, E. N., & Tropsha, A. (2017). Phantom PAINS: problems with the utility of alerts for pan-assay interference compounds. Journal of Chemical Information and Modeling, 57(3), 417-427. https://doi.org/10.1021/acs.jcim.6b00465

Chambers, J., Davies, M., Gaulton, A., Hersey, A., Velankar, S., Petryszak, R., Hastings, J., Bellis, L., McGlinchey, S., & Overington, J. P. (2013). UniChem: a unified chemical structure cross-referencing and identifier tracking system. Journal of Cheminformatics, 5, 3. https://doi.org/10.1186/1758-2946-5-3

Chandrasekhar, V., Rajan, K., Kanakam, S. R. S., Sharma, N., Weißenborn, V., Schaub, J., & Steinbeck, C. (2025). COCONUT 2.0: a comprehensive overhaul and curation of the collection of open natural products database. Nucleic Acids Research, 53(D1), D634-D643. https://doi.org/10.1093/nar/gkae1063

Chawla, N. V., Bowyer, K. W., Hall, L. O., & Kegelmeyer, W. P. (2002). SMOTE: Synthetic Minority Over-sampling Technique. Journal of Artificial Intelligence Research, 16, 321-357. https://doi.org/10.1613/jair.953

Chemprop Developers. (2024). Interpretability with Monte Carlo Tree Search — Chemprop Documentation. https://chemprop.readthedocs.io/en/main/interpreting_monte_carlo_tree_search.html

Chen, Y., de Bruyn Kops, C., & Kirchmair, J. (2017). Data Resources for the Computer-Guided Discovery of Bioactive Natural Products. Journal of Chemical Information and Modeling, 57(9), 2099-2111. https://doi.org/10.1021/acs.jcim.7b00341

Cherkasov, A., Muratov, E. N., Fourches, D., Varnek, A., Baskin, I. I., Cronin, M., Dearden, J., Gramatica, P., Martin, Y. C., Todeschini, R., Consonni, V., Kuz’min, V. E., Cramer, R., Benigni, R., Yang, C., Rathman, J., Terfloth, L., Gasteiger, J., Richard, A., & Tropsha, A. (2014). QSAR Modeling: Where Have You Been? Where Are You Going To? Journal of Medicinal Chemistry, 57(12), 4977-5010. https://doi.org/10.1021/jm4004285

Chicco, D., & Jurman, G. (2020). The advantages of the Matthews correlation coefficient (MCC) over F1 score and accuracy in binary classification evaluation. BMC Genomics, 21, 6. https://doi.org/10.1186/s12864-019-6413-7

Chithrananda, S., Grand, G., & Ramsundar, B. (2020). ChemBERTa: Large-Scale Self-Supervised Pretraining for Molecular Property Prediction. arXiv preprint arXiv:2010.09885. https://doi.org/10.48550/arXiv.2010.09885

Clark, D. E. (1999a). Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 1. Prediction of intestinal absorption. Journal of Pharmaceutical Sciences, 88(8), 807-814. https://doi.org/10.1021/js9804011

Clark, D. E. (1999b). Rapid Calculation of Polar Molecular Surface Area and Its Application to the Prediction of Transport Phenomena. 2. Prediction of Blood–Brain Barrier Penetration. Journal of Pharmaceutical Sciences, 88(8), 815-821. https://doi.org/10.1021/js980402t

Clark, D. E. (2003). In silico prediction of blood-brain barrier permeation. Drug Discovery Today, 8(20), 927-933. https://doi.org/10.1016/S1359-6446(03)02827-7

Crone, C., & Olesen, S.-P. (1982). Electrical resistance of brain microvascular endothelium. Brain Research, 241(1), 49-55. https://doi.org/10.1016/0006-8993(82)91227-6

Cruz-Monteagudo, M., Medina-Franco, J. L., Pérez-Castillo, Y., Nicolotti, O., Cordeiro, M. N. D. S., & Borges, F. (2014). Activity cliffs in drug discovery: Dr Jekyll or Mr Hyde? Drug Discovery Today, 19(8), 1069-1080. https://doi.org/10.1016/j.drudis.2014.02.003

Dablander, M., Hanser, T., Lambiotte, R., & Morris, G. M. (2024). Sort & Slice: a simple and superior alternative to hash-based folding for extended-connectivity fingerprints. Journal of Cheminformatics, 16, 135. https://doi.org/10.1186/s13321-024-00932-y

Dagenais, C., Rousselle, C., Pollack, G. M., & Scherrmann, J.-M. (2000). Development of an in situ mouse brain perfusion model and its application to mdr1a P-glycoprotein-deficient mice. Journal of Cerebral Blood Flow and Metabolism, 20(2), 381-386. https://doi.org/10.1097/00004647-200002000-00020

Dalke, A. (2020). Similarity principle variations. http://www.dalkescientific.com/writings/diary/archive/2020/09/14/similarity_principle_variations.html.

Dalke, A., Hert, J., & Kramer, C. (2018). mmpdb: An Open-Source Matched Molecular Pair Platform for Large Multiproperty Data Sets. Journal of Chemical Information and Modeling, 58(5), 902-910. https://doi.org/10.1021/acs.jcim.8b00173

Dalke, A., Hert, J., Kramer, C., & Awale, M. (2024). mmpdb: matched molecular pair database and analysis tool. https://github.com/rdkit/mmpdb.

Daneman, R., & Prat, A. (2015). The Blood-Brain Barrier. Cold Spring Harbor Perspectives in Biology, 7(1), a020412. https://doi.org/10.1101/cshperspect.a020412

Davies, M., Nowotka, M., Papadatos, G., Dedman, N., Gaulton, A., Atkinson, F., Bellis, L., & Overington, J. P. (2015). ChEMBL web services: streamlining access to drug discovery data and utilities. Nucleic Acids Research, 43(W1), W612-W620. https://doi.org/10.1093/nar/gkv352

DeepChem contributors. (s. f.). 12 SMILES strings in the BBBP dataset fail when I attempt to parse them using rdkit (Issue #2336). GitHub Issue. Recuperado https://github.com/deepchem/deepchem/issues/2336

DeepChem project. (s. f.). MoleculeNet — DeepChem documentation. https://deepchem.readthedocs.io/en/latest/moleculenet.html.

Deo, A. K., Theil, F.-P., & Nicolas, J.-M. (2013). Confounding Parameters in Preclinical Assessment of Blood-Brain Barrier Permeation: An Overview With Emphasis on Species Differences and Effect of Disease States. Molecular Pharmaceutics, 10(5), 1581-1595. https://doi.org/10.1021/mp300570z

Di, L., Kerns, E. H., Bezar, I. F., Petusky, S. L., & Huang, Y. (2009). Comparison of blood-brain barrier permeability assays: in situ brain perfusion, MDR1-MDCKII and PAMPA-BBB. Journal of Pharmaceutical Sciences, 98(6), 1980-1991. https://doi.org/10.1002/jps.21580

Di, L., Kerns, E. H., Fan, K., McConnell, O. J., & Carter, G. T. (2003). High throughput artificial membrane permeability assay for blood-brain barrier. European Journal of Medicinal Chemistry, 38(3), 223-232. https://doi.org/10.1016/s0223-5234(03)00012-6

Diener, H.-C., Lees, K. R., Lyden, P., Grotta, J., Davalos, A., Davis, S. M., Shuaib, A., Ashwood, T., Wasiewski, W., Alderfer, V., Hårdemark, H.-G., & Rodichok, L. (2008). NXY-059 for the treatment of acute stroke: pooled analysis of the SAINT I and II Trials. Stroke, 39(6), 1751-1758. https://doi.org/10.1161/STROKEAHA.107.503334

Dinkova-Kostova, A. T., Kostov, R. V., & Kazantsev, A. G. (2018). The role of Nrf2 signaling in counteracting neurodegenerative diseases. FEBS Journal, 285(19), 3576-3590. https://doi.org/10.1111/febs.14379

Egan, M. F., Kost, J., Tariot, P. N., Aisen, P. S., Cummings, J. L., Vellas, B., Sur, C., Mukai, Y., Voss, T., Furtek, C., Mahoney, E., Harper Mozley, L., Vandenberghe, R., Mo, Y., & Michelson, D. (2018). Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer’s Disease. New England Journal of Medicine, 378(18), 1691-1703. https://doi.org/10.1056/NEJMoa1706441

Egan, M. F., Kost, J., Voss, T., Mukai, Y., Aisen, P. S., Cummings, J. L., Tariot, P. N., Vellas, B., van Dyck, C. H., Boada, M., Zhang, Y., Li, W., Furtek, C., Mahoney, E., Harper Mozley, L., Mo, Y., Sur, C., & Michelson, D. (2019). Randomized Trial of Verubecestat for Prodromal Alzheimer’s Disease. New England Journal of Medicine, 380(15), 1408-1420. https://doi.org/10.1056/NEJMoa1812840

EMBL-EBI. (s. f.). ChEMBL Database. https://www.ebi.ac.uk/chembl/.

Ertl, P., Rohde, B., & Selzer, P. (2000). Fast Calculation of Molecular Polar Surface Area as a Sum of Fragment-Based Contributions and Its Application to the Prediction of Drug Transport Properties. Journal of Medicinal Chemistry, 43(20), 3714-3717. https://doi.org/10.1021/jm000942e

Evans, B. E., Rittle, K. E., Bock, M. G., DiPardo, R. M., Freidinger, R. M., Whitter, W. L., Lundell, G. F., Veber, D. F., Anderson, P. S., Chang, R. S. L., Lotti, V. J., Cerino, D. J., Chen, T. B., Kling, P. J., Kunkel, K. A., Springer, J. P., & Hirshfield, J. (1988). Methods for Drug Discovery: Development of Potent, Selective, Orally Effective Cholecystokinin Antagonists. Journal of Medicinal Chemistry, 31(12), 2235-2246. https://doi.org/10.1021/jm00120a002

Feher, M., & Schmidt, J. M. (2003). Property Distributions: Differences between Drugs, Natural Products, and Molecules from Combinatorial Chemistry. Journal of Chemical Information and Computer Sciences, 43(1), 218-227. https://doi.org/10.1021/ci0200467

Fischer, H., Gottschlich, R., & Seelig, A. (1998). Blood-Brain Barrier Permeation: Molecular Parameters Governing Passive Diffusion. Journal of Membrane Biology, 165(3), 201-211.

Free, S. M., & Wilson, J. W. (1964). A Mathematical Contribution to Structure-Activity Studies. Journal of Medicinal Chemistry, 7(4), 395-399. https://doi.org/10.1021/jm00334a001

Garberg, P., Ball, M., Borg, N., Cecchelli, R., Fenart, L., Hurst, R. D., Lindmark, T., Mabondzo, A., Nilsson, J. E., Raub, T. J., Stanimirovic, D., Terasaki, T., Öberg, J.-O., & Österberg, T. (2005). In vitro models for the blood-brain barrier. Toxicology in Vitro, 19(3), 299-334. https://doi.org/10.1016/j.tiv.2004.06.011

Ghose, A. K., Viswanadhan, V. N., & Wendoloski, J. J. (1999). A Knowledge-Based Approach in Designing Combinatorial or Medicinal Chemistry Libraries for Drug Discovery. 1. A Qualitative and Quantitative Characterization of Known Drug Databases. Journal of Combinatorial Chemistry, 1(1), 55-68. https://doi.org/10.1021/cc9800071

Gilmer, J., Schoenholz, S. S., Riley, P. F., Vinyals, O., & Dahl, G. E. (2017). Neural Message Passing for Quantum Chemistry. Proceedings of the 34th International Conference on Machine Learning (ICML).

Gogishvili, D., Nittinger, E., Margreitter, C., & Tyrchan, C. (2021). Nonadditivity in public and inhouse data: implications for drug design. Journal of Cheminformatics, 13(1), 47. https://doi.org/10.1186/s13321-021-00525-z

Golbraikh, A., & Tropsha, A. (2002). Beware of q2! Journal of Molecular Graphics and Modelling, 20(4), 269-276. https://doi.org/10.1016/S1093-3263(01)00123-1

Gramatica, P. (2007). Principles of QSAR models validation: internal and external. QSAR & Combinatorial Science, 26(5), 694-701. https://doi.org/10.1002/qsar.200610151

Gulyaev, A. E., Gelperina, S. E., Skidan, I. N., Antropov, A. S., Kivman, G. Y., & Kreuter, J. (1999). Significant Transport of Doxorubicin into the Brain with Polysorbate 80-Coated Nanoparticles. Pharmaceutical Research, 16(10), 1564-1569. https://doi.org/10.1023/a:1018983904537

Gürbüz, P., Doğan, Ş., Gündüz, M., Martínez-González, L., Pérez, C., & Martínez, A. (2025). Screening Natural Phenolic Compounds for Blood-Brain Barrier Permeability, Alongside GSK-3\(\beta\), CK-1\(\delta\), and AChE Inhibition, for the Treatment of Alzheimer’s Disease. Drug Development Research, 86(8), e70193. https://doi.org/10.1002/ddr.70193

Hammarlund-Udenaes, M., Fridén, M., Syvänen, S., & Gupta, A. (2008). On the Rate and Extent of Drug Delivery to the Brain. Pharmaceutical Research, 25(8), 1737-1750. https://doi.org/10.1007/s11095-007-9502-2

Hansch, C., & Fujita, T. (1964). ρ-σ-π Analysis. A Method for the Correlation of Biological Activity and Chemical Structure. Journal of the American Chemical Society, 86(8), 1616-1626. https://doi.org/10.1021/ja01062a035

Hardy, J., & Selkoe, D. J. (2002). The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics. Science, 297(5580), 353-356. https://doi.org/10.1126/science.1072994

He, H., & Garcia, E. A. (2009). Learning from Imbalanced Data. IEEE Transactions on Knowledge and Data Engineering, 21(9), 1263-1284. https://doi.org/10.1109/TKDE.2008.239

Heinrich, M., & Teoh, H. L. (2004). Galanthamine from snowdrop—the development of a modern drug against Alzheimer’s disease from local Caucasian knowledge. Journal of Ethnopharmacology, 92(2-3), 147-162. https://doi.org/10.1016/j.jep.2004.02.012

Heller, S. R., McNaught, A., Pletnev, I., Stein, S., & Tchekhovskoi, D. (2015). InChI, the IUPAC International Chemical Identifier. Journal of Cheminformatics, 7, 23. https://doi.org/10.1186/s13321-015-0068-4

Hellinger, É., Veszelka, S., Tóth, A. E., Walter, F., Kittel, Á., Bakk, M. L., Tihanyi, K., Háda, V., Nakagawa, S., Duy, T. D., Niwa, M., Deli, M. A., & Vastag, M. (2012). Comparison of brain capillary endothelial cell-based and epithelial (MDCK-MDR1, Caco-2, and VB-Caco-2) cell-based surrogate blood-brain barrier penetration models. European Journal of Pharmaceutics and Biopharmaceutics, 82(2), 340-351. https://doi.org/10.1016/j.ejpb.2012.07.020

Heneka, M. T., & Feinstein, D. L. (2001). Expression and function of inducible nitric oxide synthase in neurons. Journal of Neuroimmunology, 114(1-2), 8-18. https://doi.org/10.1016/s0165-5728(01)00246-6

Heneka, M. T., Kummer, M. P., Stutz, A., Delekate, A., Schwartz, S., Vieira-Saecker, A., Griep, A., Axt, D., Remus, A., Tzeng, T.-C., Gelpi, E., Halle, A., Korte, M., Latz, E., & Golenbock, D. T. (2013). NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice. Nature, 493(7434), 674-678. https://doi.org/10.1038/nature11729

Herrup, K. (2015). The case for rejecting the amyloid cascade hypothesis. Nature Neuroscience, 18(6), 794-799. https://doi.org/10.1038/nn.4017

Hou, D., Lin, H., Feng, Y., Zhou, K., Li, X., Yang, Y., Wang, S., Yang, X., Wang, J., Zhao, H., Zhang, X., Fan, J., Lu, S., Wang, D., Zhu, L., Ju, D., Chen, Y. Z., & Zeng, X. (2024). CMAUP database update 2024: extended functional and association information of useful plants for biomedical research. Nucleic Acids Research, 52(D1), D1508-D1518. https://doi.org/10.1093/nar/gkad921

Huang, E. T. C., Yang, J.-S., Liao, K. Y. K., Tseng, W. C. W., Lee, C. K., Gill, M., Compas, C., See, S., & Tsai, F.-J. (2024). Predicting blood-brain barrier permeability of molecules with a large language model and machine learning. Scientific Reports, 14, 15844. https://doi.org/10.1038/s41598-024-66897-y

Huang, K., Fu, T., Gao, W., Zhao, Y., Roohani, Y., Leskovec, J., Coley, C. W., Xiao, C., Sun, J., & Zitnik, M. (2021). Therapeutics Data Commons: Machine Learning Datasets and Tasks for Drug Discovery and Development. Proceedings of Neural Information Processing Systems, NeurIPS Datasets and Benchmarks Track. https://arxiv.org/abs/2102.09548

Hussain, J., & Rea, C. (2010). Computationally Efficient Algorithm to Identify Matched Molecular Pairs (MMPs) in Large Data Sets. Journal of Chemical Information and Modeling, 50(3), 339-348. https://doi.org/10.1021/ci900450m

Hynynen, K., McDannold, N., Vykhodtseva, N., & Jolesz, F. A. (2001). Noninvasive MR Imaging-guided Focal Opening of the Blood-Brain Barrier in Rabbits. Radiology, 220(3), 640-646. https://doi.org/10.1148/radiol.2202001804

Ingólfsson, H. I., Thakur, P., Herold, K. F., Hobart, E. A., Ramsey, N. B., Periole, X., de Jong, D. H., Zwama, M., Yilmaz, D., Hall, K., Maretzky, T., Hemmings, H. C., Blobel, C., Marrink, S. J., Koçer, A., Sack, J. T., & Andersen, O. S. (2014). Phytochemicals perturb membranes and promiscuously alter protein function. ACS Chemical Biology, 9(8), 1788-1798. https://doi.org/10.1021/cb500086e

Irwin, J. J., Tang, K. G., Young, J., Dandarchuluun, C., Wong, B. R., Khurelbaatar, M., Moroz, Y. S., Mayfield, J., & Sayle, R. A. (2020). ZINC20—A Free Ultralarge-Scale Chemical Database for Ligand Discovery. Journal of Chemical Information and Modeling, 60(12), 6065-6073. https://doi.org/10.1021/acs.jcim.0c00675

Jain, S., & Wallace, B. C. (2019). Attention is not Explanation. Proceedings of NAACL-HLT 2019.

Jin, W., Barzilay, R., & Jaakkola, T. (2020). Multi-Objective Molecule Generation using Interpretable Substructures. Proceedings of the 37th International Conference on Machine Learning (ICML).

Johnson, M. A., & Maggiora, G. M. (Eds.). (1990). Concepts and Applications of Molecular Similarity. John Wiley & Sons.

Karran, E., Mercken, M., & De Strooper, B. (2011). The amyloid cascade hypothesis for Alzheimer’s disease: an appraisal for the development of therapeutics. Nature Reviews Drug Discovery, 10(9), 698-712. https://doi.org/10.1038/nrd3505

Kato, R., Zhang, L., Kinatukara, N., Huang, R., Asthana, A., Weber, C., Xia, M., Xu, X., & Shah, P. (2025). Investigating blood–brain barrier penetration and neurotoxicity of natural products for central nervous system drug development. Scientific Reports, 15, 7431. https://doi.org/10.1038/s41598-025-90888-2

Khaouane, A., Ferhat, S., & Hanini, S. (2023). A Quantitative Structure-Activity Relationship for Human Plasma Protein Binding: Prediction, Validation and Applicability Domain. Advanced Pharmaceutical Bulletin, 13(4), 784-791. https://doi.org/10.34172/apb.2023.078

Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998). Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature, 392(6676), 605-608. https://doi.org/10.1038/33416

Knox, C., Wilson, M., Klinger, C. M., Franklin, M., Oler, E., Wilson, A., Pon, A., Cox, J., Chin, N. E., Strawbridge, S. A., Garcia-Patino, M., Kruger, R., Sivakumaran, A., Sanford, S., Doshi, R., Khetarpal, N., Fatokun, O., Doucet, D., Zubkowski, A., … Wishart, D. S. (2024). DrugBank 6.0: the DrugBank Knowledgebase for 2024. Nucleic Acids Research, 52(D1), D1265-D1275. https://doi.org/10.1093/nar/gkad976

Krenn, M., Häse, F., Nigam, A. K., Friederich, P., & Aspuru-Guzik, A. (2020). Self-referencing embedded strings (SELFIES): A 100% robust molecular string representation. Machine Learning: Science and Technology, 1(4), 045024. https://arxiv.org/abs/1905.13741

Kreuter, J. (2001). Nanoparticulate systems for brain delivery of drugs. Advanced Drug Delivery Reviews, 47(1), 65-81. https://doi.org/10.1016/s0169-409x(00)00122-8

Kreuter, J., Alyautdin, R. N., Kharkevich, D. A., & Ivanov, A. A. (1995). Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles). Brain Research, 674(1), 171-174. https://doi.org/10.1016/0006-8993(95)00023-j

Kumar, I. E., Venkatasubramanian, S., Scheidegger, C., & Friedler, S. (2020). Problems with Shapley-value-based explanations as feature importance measures. Proceedings of the 37th International Conference on Machine Learning, PMLR, 119, 5491-5500.

Kusuhara, H., & Sugiyama, Y. (2005). Active efflux across the blood-brain barrier: role of the solute carrier family. NeuroRx, 2(1), 73-85. https://doi.org/10.1602/neurorx.2.1.73

Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., Wals, P., Zhang, C., Finch, C. E., Krafft, G. A., & Klein, W. L. (1998). Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proceedings of the National Academy of Sciences, 95(11), 6448-6453. https://doi.org/10.1073/pnas.95.11.6448

Landrum, G. (2023). FingerprintGenerator tutorial. Blog de RDKit, https://greglandrum.github.io/rdkit-blog/posts/2023-01-18-fingerprint-generator-tutorial.html.

Landrum, G. (2025). Updated bit rendering. Blog de RDKit, https://greglandrum.github.io/rdkit-blog/posts/2025-03-29-updated-bit-rendering.html.

Landrum, G., & RDKit contributors. (2026). RDKit: Open-Source Cheminformatics Software. https://www.rdkit.org.

LeWitt, P. A., Guttman, M., Tetrud, J. W., Tuite, P. J., Mori, A., Chaikin, P., & Sussman, N. M. (2008). Adenosine A2A receptor antagonist istradefylline (KW-6002) reduces "off" time in Parkinson’s disease: a double-blind, randomized, multicenter clinical trial (6002-US-005). Annals of Neurology, 63(3), 295-302. https://doi.org/10.1002/ana.21315

Li, J., Qu, X., Zhang, W., & Zhong, S. (2026). Collision-free morgan fingerprints: a principled approach to enhance machine learning performance and interpretability in chemistry. Journal of Cheminformatics, 18, 46. https://doi.org/10.1186/s13321-026-01170-0

Lin, H., Hou, D., Jiang, X., Yin, R., Yu, S., Lu, S., Wang, S., Ju, D., Zhao, H., Chen, Y., & Zeng, X. (2026). NPASS database update 2026: comprehensive quantitative composition, bioactivity, and ADME-Tox data of natural products for biomedical research. Nucleic Acids Research, 54(D1), D1519-D1527. https://doi.org/10.1093/nar/gkaf1196

Lin, M. T., & Beal, M. F. (2006). Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature, 443(7113), 787-795. https://doi.org/10.1038/nature05292

Lipinski, C. A. (2000). Drug-like properties and the causes of poor solubility and poor permeability. Journal of Pharmacological and Toxicological Methods, 44(1), 235-249. https://doi.org/10.1016/s1056-8719(00)00107-6

Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews, 46(1–3), 3-26. https://doi.org/10.1016/S0169-409X(00)00129-0

Lloyd, K., & Hornykiewicz, O. (1970). Parkinson’s Disease: Activity of L-Dopa Decarboxylase in Discrete Brain Regions. Science, 170(3963), 1212-1213. https://doi.org/10.1126/science.170.3963.1212

Lochhead, J. J., & Thorne, R. G. (2012). Intranasal delivery of biologics to the central nervous system. Advanced Drug Delivery Reviews, 64(7), 614-628. https://doi.org/10.1016/j.addr.2011.11.002

Lohmann, C., Hüwel, S., & Galla, H.-J. (2002). Predicting blood-brain barrier permeability of drugs: evaluation of different in vitro assays. Journal of Drug Targeting, 10(4), 263-276. https://doi.org/10.1080/10611860290031903

Loryan, I., Reichel, A., Feng, B., Bundgaard, C., Shaffer, C., Kalvass, C., Bednarczyk, D., Morrison, D., Lesuisse, D., Hoppe, E., Terstappen, G. C., Fischer, H., Di, L., Colclough, N., Summerfield, S., Buckley, S. T., Maurer, T. S., & Fridén, M. (2022). Unbound Brain-to-Plasma Partition Coefficient, Kp,uu,brain—a Game Changing Parameter for CNS Drug Discovery and Development. Pharmaceutical Research, 39(7), 1321-1341. https://doi.org/10.1007/s11095-022-03246-6

Löscher, W., & Potschka, H. (2005). Blood-brain barrier active efflux transporters: ATP-binding cassette gene family. NeuroRx, 2(1), 86-98. https://doi.org/10.1602/neurorx.2.1.86

Lovering, F., Bikker, J., & Humblet, C. (2009). Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success. Journal of Medicinal Chemistry, 52(21), 6752-6756. https://doi.org/10.1021/jm901241e

Maggiora, G. M. (2006). On Outliers and Activity Cliffs — Why QSAR Often Disappoints. Journal of Chemical Information and Modeling, 46(4), 1535. https://doi.org/10.1021/ci060117s

Maggiora, G., Vogt, M., Stumpfe, D., & Bajorath, J. (2014). Molecular Similarity in Medicinal Chemistry. Journal of Medicinal Chemistry, 57(8), 3186-3204. https://doi.org/10.1021/jm401411z

Mahar Doan, K. M., Humphreys, J. E., Webster, L. O., Wring, S. A., Shampine, L. J., Serabjit-Singh, C. J., Adkison, K. K., & Polli, J. W. (2002). Passive Permeability and P-Glycoprotein-Mediated Efflux Differentiate Central Nervous System (CNS) and Non-CNS Marketed Drugs. Journal of Pharmacology and Experimental Therapeutics, 303(3), 1029-1037. https://doi.org/10.1124/jpet.102.039255

Martin, T. M., Harten, P., Young, D. M., Muratov, E. N., Golbraikh, A., Zhu, H., & Tropsha, A. (2012). Does Rational Selection of Training and Test Sets Improve the Outcome of QSAR Modeling? Journal of Chemical Information and Modeling, 52(10), 2570-2578. https://doi.org/10.1021/ci300338w

Martin, Y. C. (2012). Hansch analysis 50 years on. WIREs Computational Molecular Science, 2(3), 435-442. https://doi.org/10.1002/wcms.1096

Martins, I. F., Teixeira, A. L., Pinheiro, L., & Falcão, A. O. (2012). A Bayesian Approach to in Silico Blood-Brain Barrier Penetration Modeling. Journal of Chemical Information and Modeling, 52(6), 1686-1697. https://doi.org/10.1021/ci300124c

McDannold, N., Vykhodtseva, N., Raymond, S., Jolesz, F. A., & Hynynen, K. (2005). MRI-Guided Targeted Blood-Brain Barrier Disruption with Focused Ultrasound: Histological Findings in Rabbits. Ultrasound in Medicine and Biology, 31(11), 1527-1537. https://doi.org/10.1016/j.ultrasmedbio.2005.07.010

Meng, F., Chen, J., Collins-Ramirez, J. S., & Ayers, P. W. (2025). B3clf: A Resampling-Integrated Machine Learning Framework to Predict Blood-Brain Barrier Permeability. Preprint en ChemRxiv. https://doi.org/10.26434/chemrxiv-2025-xschc

Meng, F., Collins-Ramirez, J. S., & Ayers, P. W. (2023). B3clf: Blood-Brain Barrier Classifiers (Versión 0.0.1) [Software]. https://doi.org/10.5281/zenodo.8336769

Meng, F., Xi, Y., Huang, J., & Ayers, P. W. (2021a). A curated diverse molecular database of blood-brain barrier permeability with chemical descriptors. Scientific Data, 8(1), 289. https://doi.org/10.1038/s41597-021-01069-5

Meng, F., Xi, Y., Huang, J., & Ayers, P. W. (2021b). A large benchmark dataset, Blood-Brain Barrier Database (B3DB), compiled from 50 published resources. Figshare dataset. https://doi.org/10.6084/m9.figshare.15634230.v3

Minghetti, L. (2004). Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases. Journal of Neuropathology and Experimental Neurology, 63(9), 901-910. https://doi.org/10.1093/jnen/63.9.901

Moriwaki, H., & contributors. (2018). mordred (paquete de PyPI). https://github.com/mordred-descriptor/mordred.

Moriwaki, H., Tian, Y.-S., Kawashita, N., & Takagi, T. (2018). Mordred: a molecular descriptor calculator. Journal of Cheminformatics, 10, 4. https://doi.org/10.1186/s13321-018-0258-y

Muratov, E. N., Bajorath, J., Sheridan, R. P., Tetko, I. V., Filimonov, D., Poroikov, V., Oprea, T. I., Baskin, I. I., Varnek, A., Roitberg, A., Isayev, O., Curtalolo, S., Fourches, D., Cohen, Y., Aspuru-Guzik, A., Winkler, D. A., Agrafiotis, D., Cherkasov, A., & Tropsha, A. (2020). QSAR without borders. Chemical Society Reviews, 49(11), 3525-3564. https://doi.org/10.1039/d0cs00098a

Nelson, K. M., Dahlin, J. L., Bisson, J., Graham, J., Pauli, G. F., & Walters, M. A. (2017). The Essential Medicinal Chemistry of Curcumin. Journal of Medicinal Chemistry, 60(5), 1620-1637. https://doi.org/10.1021/acs.jmedchem.6b00975

Netzeva, T. I., Worth, A., Aldenberg, T., Benigni, R., Cronin, M. T. D., Gramatica, P., Jaworska, J. S., Kahn, S., Klopman, G., Marchant, C. A., Myatt, G., Nikolova-Jeliazkova, N., Patlewicz, G. Y., Perkins, R., Roberts, D., Schultz, T. W., Stanton, D. W., Sandt, J. J. M. van de, Tong, W., … Yang, C. (2005). Current status of methods for defining the applicability domain of (quantitative) structure-activity relationships. The report and recommendations of ECVAM Workshop 52. Alternatives to Laboratory Animals (ATLA), 33(2), 155-173. https://doi.org/10.1177/026119290503300209

Norinder, U., Carlsson, L., Boyer, S., & Eklund, M. (2014). Introducing Conformal Prediction in Predictive Modeling. A Transparent and Flexible Alternative to Applicability Domain Determination. Journal of Chemical Information and Modeling, 54(6), 1596-1603. https://doi.org/10.1021/ci5001168

Norinder, U., Carlsson, L., Boyer, S., & Eklund, M. (2015). Introducing conformal prediction in predictive modeling for regulatory purposes. A transparent and flexible alternative to applicability domain determination. Regulatory Toxicology and Pharmacology, 71(2), 279-284. https://doi.org/10.1016/j.yrtph.2014.12.021

O’Boyle, N. M. (2012). Towards a Universal SMILES representation — A standard method to generate canonical SMILES based on the InChI. Journal of Cheminformatics, 4, 22. https://doi.org/10.1186/1758-2946-4-22

O’Brien, R. J., & Wong, P. C. (2011). Amyloid precursor protein processing and Alzheimer’s disease. Annual Review of Neuroscience, 34, 185-204. https://doi.org/10.1146/annurev-neuro-061010-113613

O’Collins, V. E., Macleod, M. R., Donnan, G. A., Horky, L. L., van der Worp, B. H., & Howells, D. W. (2006). 1,026 experimental treatments in acute stroke. Annals of Neurology, 59(3), 467-477. https://doi.org/10.1002/ana.20741

OECD. (2007). Guidance Document on the Validation of (Quantitative) Structure-Activity Relationship [(Q)SAR] Models (ENV/JM/MONO(2007)2, OECD Series on Testing and Assessment No. 69). OECD Environment Directorate.

Paisán-Ruiz, C., Jain, S., Evans, E. W., Gilks, W. P., Simón, J., Brug, M. van der, López de Munain, A., Aparicio, S., Gil, A. M., Khan, N., Johnson, J., Martinez, J. R., Nicholl, D., Martí Carrera, I., Pena, A. S., Silva, R. de, Lees, A., Martí-Massó, J. F., Pérez-Tur, J., … Singleton, A. B. (2004). Cloning of the gene containing mutations that cause PARK8-linked Parkinson’s disease. Neuron, 44(4), 595-600. https://doi.org/10.1016/j.neuron.2004.10.023

Pajouhesh, H., & Lenz, G. R. (2005). Medicinal Chemical Properties of Successful Central Nervous System Drugs. NeuroRx, 2(4), 541-553. https://doi.org/10.1602/neurorx.2.4.541

Pardridge, W. M. (2001). Brain Drug Targeting: The Future of Brain Drug Development. Cambridge University Press.

Pardridge, W. M. (2005). The Blood-Brain Barrier: Bottleneck in Brain Drug Development. NeuroRx, 2(1), 3-14. https://doi.org/10.1602/neurorx.2.1.3

Pardridge, W. M. (2006). Molecular Trojan horses for blood-brain barrier drug delivery. Current Opinion in Pharmacology, 6(5), 494-500. https://doi.org/10.1016/j.coph.2006.06.001

Pardridge, W. M. (2012). Drug transport across the blood-brain barrier. Journal of Cerebral Blood Flow and Metabolism, 32(11), 1959-1972. https://doi.org/10.1038/jcbfm.2012.126

Parkinson Study Group. (1993). Effects of tocopherol and deprenyl on the progression of disability in early Parkinson’s disease. New England Journal of Medicine, 328(3), 176-183. https://doi.org/10.1056/NEJM199301213280305

Pergolizzi, J., Varrassi, G., Coleman, M., Breve, F., Christo, D. K., Christo, P. J., & Moussa, C. (2023). The Sigma Enigma: A Narrative Review of Sigma Receptors. Cureus, 15(3), e35756. https://doi.org/10.7759/cureus.35756

Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., Stenroos, E. S., Chandrasekharappa, S., Athanassiadou, A., Papapetropoulos, T., Johnson, W. G., Lazzarini, A. M., Duvoisin, R. C., Di Iorio, G., Golbe, L. I., & Nussbaum, R. L. (1997). Mutation in the alpha-synuclein gene identified in families with Parkinson’s disease. Science, 276(5321), 2045-2047. https://doi.org/10.1126/science.276.5321.2045

Poynton, E. F., Santen, J. A. van, Pin, M., Contreras, M. M., McMann, E., Parra, J., Showalter, B., Zaroubi, L., Duncan, K. R., & Linington, R. G. (2024). The Natural Products Atlas 3.0: Extending the Database of Microbially-Derived Natural Products. Nucleic Acids Research, gkae1093. https://doi.org/10.1093/nar/gkae1093

Praski, M., Adamczyk, J., & Czech, W. (2026). Benchmarking Pretrained Molecular Embedding Models For Molecular Representation Learning. arXiv preprint arXiv:2508.06199. https://arxiv.org/abs/2508.06199

Pulgar, V. M. (2018). Transcytosis to Cross the Blood Brain Barrier, New Advancements and Challenges. Frontiers in Neuroscience, 12, 1019. https://doi.org/10.3389/fnins.2018.01019

Qin, H., Hashem, A. F., Hanif, M. F., & Fiidow, O. A. (2025). Graph theoretic and machine learning approaches in molecular property prediction of bladder cancer therapeutics. Scientific Reports, 15, 28025. https://doi.org/10.1038/s41598-025-14175-w

Rafii, M. S., Walsh, S., Little, J. T., Behan, K., Reynolds, B., Ward, C., Jin, S., Thomas, R., & Aisen, P. S. (2011). A phase II trial of huperzine A in mild to moderate Alzheimer disease. Neurology, 76(16), 1389-1394. https://doi.org/10.1212/WNL.0b013e318216eb7b

Randić, M. (1975). Characterization of Molecular Branching. Journal of the American Chemical Society, 97(23), 6609-6615. https://doi.org/10.1021/ja00856a001

Rao, J., Zheng, S., Lu, Y., & Yang, Y. (2022). Quantitative evaluation of explainable graph neural networks for molecular property prediction. Patterns, 3(12), 100628. https://doi.org/10.1016/j.patter.2022.100628

Rautio, J., Kumpulainen, H., Heimbach, T., Oliyai, R., Oh, D., Järvinen, T., & Savolainen, J. (2008). Prodrugs: design and clinical applications. Nature Reviews Drug Discovery, 7(3), 255-270. https://doi.org/10.1038/nrd2468

RDKit developers. (s. f.). rdkit.Chem.Scaffolds.MurckoScaffold module. https://www.rdkit.org/docs/source/rdkit.Chem.Scaffolds.MurckoScaffold.html.

Reisberg, B., Doody, R., Stöffler, A., Schmitt, F., Ferris, S., & Möbius, H. J. (2003). Memantine in Moderate-to-Severe Alzheimer’s Disease. New England Journal of Medicine, 348(14), 1333-1341. https://doi.org/10.1056/NEJMoa013128

Rodrigues, T., Reker, D., Schneider, P., & Schneider, G. (2016). Counting on natural products for drug design. Nature Chemistry, 8(6), 531-541. https://doi.org/10.1038/nchem.2479

Rodríguez-Pérez, R., & Bajorath, J. (2020). Interpretation of machine learning models using shapley values: application to compound potency and multi-target activity predictions. Journal of Computer-Aided Molecular Design, 34(10), 1013-1026. https://doi.org/10.1007/s10822-020-00314-0

Rogers, D., & Hahn, M. (2010). Extended-Connectivity Fingerprints. Journal of Chemical Information and Modeling, 50(5), 742-754. https://doi.org/10.1021/ci100050t

Ross, J., Belgodere, B., Chenthamarakshan, V., Padhi, I., Mroueh, Y., & Das, P. (2022). Large-Scale Chemical Language Representations Capture Molecular Structure and Properties. Nature Machine Intelligence, 4(12), 1256-1264. https://doi.org/10.1038/s42256-022-00580-7

Rücker, C., Rücker, G., & Meringer, M. (2007). y-Randomization and Its Variants in QSPR/QSAR. Journal of Chemical Information and Modeling, 47(6), 2345-2357. https://doi.org/10.1021/ci700157b

Rudin, C. (2019). Stop explaining black box machine learning models for high stakes decisions and use interpretable models instead. Nature Machine Intelligence, 1(5), 206-215. https://doi.org/10.1038/s42256-019-0048-x

Rutz, A., Sorokina, M., Galgonek, J., Mietchen, D., Willighagen, E., Gaudry, A., Graham, J. G., Stephan, R., Page, R., Vondrášek, J., Steinbeck, C., Pauli, G. F., Wolfender, J.-L., Bisson, J., & Allard, P.-M. (2022). The LOTUS initiative for open knowledge management in natural products research. eLife, 11, e70780. https://doi.org/10.7554/eLife.70780

Sahigara, F., Mansouri, K., Ballabio, D., Mauri, A., Consonni, V., & Todeschini, R. (2012). Comparison of Different Approaches to Define the Applicability Domain of QSAR Models. Molecules, 17(5), 4791-4810. https://doi.org/10.3390/molecules17054791

Saito, T., & Rehmsmeier, M. (2015). The Precision-Recall Plot Is More Informative than the ROC Plot When Evaluating Binary Classifiers on Imbalanced Datasets. PLoS ONE, 10(3), e0118432. https://doi.org/10.1371/journal.pone.0118432

Sanchez-Lengeling, B., Wei, J. N., Lee, B. K., Reif, E., Wang, P., Qian, W. W., McCloskey, K., Colwell, L. J., & Wiltschko, A. B. (2020). Evaluating Attribution for Graph Neural Networks. Advances in Neural Information Processing Systems 33 (NeurIPS 2020).

Sayas, C. L., & Ávila, J. (2021). GSK-3 and Tau: A Key Duet in Alzheimer’s Disease. Cells, 10(4), 721. https://doi.org/10.3390/cells10040721

Schapira, A. H. V., Cooper, J. M., Dexter, D., Jenner, P., Clark, J. B., & Marsden, C. D. (1989). Mitochondrial complex I deficiency in Parkinson’s disease. Lancet, 1(8649), 1269. https://doi.org/10.1016/s0140-6736(89)92366-0

Schuffenhauer, A., Ertl, P., Roggo, S., Wetzel, S., Koch, M. A., & Waldmann, H. (2007). The Scaffold Tree — Visualization of the Scaffold Universe by Hierarchical Scaffold Classification. Journal of Chemical Information and Modeling, 47(1), 47-58. https://doi.org/10.1021/ci600338x

Schuh, M. G., Daniluk, A., & Sieber, S. A. (2026). Auditing widely used biomolecular benchmarks reveals systematic data inconsistencies. Chemical Science. https://doi.org/10.1039/d6sc01799a

Seshadri, A., Wellawatte, G. P., & White, A. D. (2025). exmol: Explainer for black box models that predict molecule properties. https://github.com/ur-whitelab/exmol.

Shaker, B., Yu, M.-S., Song, J. S., Ahn, S., Ryu, J. Y., Oh, K.-S., & Na, D. (2021). LightBBB: computational prediction model of blood-brain-barrier penetration based on LightGBM. Bioinformatics, 37(8), 1135-1139. https://doi.org/10.1093/bioinformatics/btaa918

Sheridan, R. P. (2013). Time-Split Cross-Validation as a Method for Estimating the Goodness of Prospective Prediction. Journal of Chemical Information and Modeling, 53(4), 783-790. https://doi.org/10.1021/ci400084k

Shuaib, A., Lees, K. R., Lyden, P., Grotta, J., Davalos, A., Davis, S. M., Diener, H.-C., Ashwood, T., Wasiewski, W. W., & Emeribe, U. (2007). NXY-059 for the treatment of acute ischemic stroke. New England Journal of Medicine, 357(6), 562-571. https://doi.org/10.1056/NEJMoa070240

Sidransky, E., Nalls, M. A., Aasly, J. O., Aharon-Peretz, J., Annesi, G., Barbosa, E. R., Bar-Shira, A., Berg, D., Bras, J., Brice, A., Chen, C.-M., Clark, L. N., Condroyer, C., De Marco, E. V., Dürr, A., Eblan, M. J., Fahn, S., Farrer, M. J., Fung, H.-C., … Ziegler, S. G. (2009). Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson’s Disease. New England Journal of Medicine, 361(17), 1651-1661. https://doi.org/10.1056/NEJMoa0901281

Sims, J. R., Zimmer, J. A., Evans, C. D., Lu, M., Ardayfio, P., Sparks, J., Wessels, A. M., Shcherbinin, S., Wang, H., Monkul Nery, E. S., Collins, E. C., Solomon, P., Salloway, S., Apostolova, L. G., Hansson, O., Ritchie, C., Brooks, D. A., Mintun, M., & Skovronsky, D. M. (2023). Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical Trial. JAMA, 330(6), 512-527. https://doi.org/10.1001/jama.2023.13239

Smith, Q. R., Mandula, H., Parepally, J. M. R., Oki, J., Thomas, F., Thorsheim, H. R., Al-Ahmad, A. J., Abbruscato, T. J., Ask, P., Hage, D. S., & Robinson, P. J. (2024). Brain endothelial permeability, transport, and flow assessed over 10 orders of magnitude using the in situ brain perfusion technique. Fluids and Barriers of the CNS, 21, 100. https://doi.org/10.1186/s12987-024-00584-y

Spielvogel, C. P., Schindler, N., Schröder, C., Stellnberger, S. L., Wadsak, W., Mitterhauser, M., Papp, L., Hacker, M., Pichler, V., & Vraka, C. (2025). Enhancing Blood-Brain Barrier Penetration Prediction by Machine Learning-Based Integration of Novel and Existing, In Silico and Experimental Molecular Parameters from a Standardized Database. Journal of Chemical Information and Modeling, 65(6), 2773-2784. https://doi.org/10.1021/acs.jcim.4c02212

Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997). Alpha-synuclein in Lewy bodies. Nature, 388(6645), 839-840. https://doi.org/10.1038/42166

Stratton, C. F., Newman, D. J., & Tan, D. S. (2015). Cheminformatic comparison of approved drugs from natural product versus synthetic origins. Bioorganic & Medicinal Chemistry Letters, 25(21), 4802-4807. https://doi.org/10.1016/j.bmcl.2015.07.014

Stumpfe, D., & Bajorath, J. (2012). Exploring Activity Cliffs in Medicinal Chemistry. Journal of Medicinal Chemistry, 55(7), 2932-2942. https://doi.org/10.1021/jm201706b

Stumpfe, D., Hu, H., & Bajorath, J. (2019). Evolving Concept of Activity Cliffs. ACS Omega, 4(11), 14360-14368. https://doi.org/10.1021/acsomega.9b02221

Suay-García, B., Bueso-Bordils, J. I., Falcó, A., Antón-Fos, G. M., & Alemán-López, P. A. (2022). Virtual Combinatorial Chemistry and Pharmacological Screening: A Short Guide to Drug Design. International Journal of Molecular Sciences, 23(3), 1620. https://doi.org/10.3390/ijms23031620

Sun, J., Jeliazkova, N., Chupakhin, V., Golib-Dzib, J. F., Engkvist, O., Carlsson, L., Wegner, J. K., Ceulemans, H., Georgiev, I., Jeliazkov, V., Kochev, N., Ashby, T. J., & Chen, H. (2017). ExCAPE-DB: an integrated large scale dataset facilitating Big Data analysis in chemogenomics. Journal of Cheminformatics, 9, 17. https://doi.org/10.1186/s13321-017-0203-5

Sweeney, M. D., Zhao, Z., Montagne, A., Nelson, A. R., & Zlokovic, B. V. (2019). Blood-Brain Barrier: From Physiology to Disease and Back. Physiological Reviews, 99(1), 21-78. https://doi.org/10.1152/physrev.00050.2017

Takasato, Y., Rapoport, S. I., & Smith, Q. R. (1984). An in situ brain perfusion technique to study cerebrovascular transport in the rat. American Journal of Physiology, 247(3 Pt 2), H484-H493. https://doi.org/10.1152/ajpheart.1984.247.3.h484

Tamura, S., Jasial, S., Miyao, T., & Funatsu, K. (2021). Interpretation of Ligand-Based Activity Cliff Prediction Models Using the Matched Molecular Pair Kernel. Molecules, 26(16), 4916. https://doi.org/10.3390/molecules26164916

theochem. (2021). B3DB: A large benchmark dataset, Blood-Brain Barrier Database. Repositorio de GitHub. https://github.com/theochem/B3DB

Therapeutics Data Commons. (s. f.). BBB_Martins Leaderboard. https://tdcommons.ai/benchmark/admet_group/07bbb/.

Tingle, B. I., Tang, K. G., Castanon, M., Gutierrez, J. J., Khurelbaatar, M., Dandarchuluun, C., Moroz, Y. S., & Irwin, J. J. (2023). ZINC-22—A Free Multi-Billion-Scale Database of Tangible Compounds for Ligand Discovery. Journal of Chemical Information and Modeling, 63(4), 1166-1176. https://doi.org/10.1021/acs.jcim.2c01253

Tiwari, S., Mądra-Gackowska, K., Gackowski, M., & Szeleszczuk, Ł. (2026a). Evaluating the Incremental Value of Three-Dimensional Conformer Descriptors for Blood-Brain Barrier Permeability Prediction Using the B3DB Benchmark Dataset. Pharmaceutics, 18(8), 1018. https://doi.org/10.3390/pharmaceutics18081018

Tiwari, S., Mądra-Gackowska, K., Gackowski, M., & Szeleszczuk, Ł. (2026b). Quantitative Structural Thresholds for Blood-Brain Barrier Permeability Derived from Experimental logBB Measurements. Pharmaceutics, 18(8), 967. https://doi.org/10.3390/pharmaceutics18080967

Todeschini, R., & Consonni, V. (2000). Handbook of Molecular Descriptors. Wiley-VCH. https://doi.org/10.1002/9783527613106

Todeschini, R., & Consonni, V. (2009). Molecular Descriptors for Chemoinformatics. Wiley-VCH.

Turner, R. S., Thomas, R. G., Craft, S., van Dyck, C. H., Mintzer, J., Reynolds, B. A., Brewer, J. B., Rissman, R. A., Raman, R., & Aisen, P. S. (2015). A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease. Neurology, 85(16), 1383-1391. https://doi.org/10.1212/WNL.0000000000002035

U.S. Environmental Protection Agency. (2012). Sustainable Futures / P2 Framework Manual 2012, Appendix F: SMILES Notation Tutorial (EPA-748-B12-001). U.S. EPA, Office of Pollution Prevention; Toxics.

Valente, E. M., Abou-Sleiman, P. M., Caputo, V., Muqit, M. M. K., Harvey, K., Gispert, S., Ali, Z., Del Turco, D., Bentivoglio, A. R., Healy, D. G., Albanese, A., Nussbaum, R., González-Maldonado, R., Deller, T., Salvi, S., Cortelli, P., Gilks, W. P., Latchman, D. S., Harvey, R. J., … Wood, N. W. (2004). Hereditary early-onset Parkinson’s disease caused by mutations in PINK1. Science, 304(5674), 1158-1160. https://doi.org/10.1126/science.1096284

van Dyck, C. H., Swanson, C. J., Aisen, P., Bateman, R. J., Chen, C., Gee, M., Kanekiyo, M., Li, D., Reyderman, L., Cohen, S., Froelich, L., Katayama, S., Sabbagh, M., Vellas, B., Watson, D., Dhadda, S., Irizarry, M., Kramer, L. D., & Iwatsubo, T. (2023). Lecanemab in Early Alzheimer’s Disease. New England Journal of Medicine, 388(1), 9-21. https://doi.org/10.1056/NEJMoa2212948

van Tilborg, D., Alenicheva, A., & Grisoni, F. (2022). Exposing the Limitations of Molecular Machine Learning with Activity Cliffs. Journal of Chemical Information and Modeling, 62(23), 5938-5951. https://doi.org/10.1021/acs.jcim.2c01073

Varin, T., Schuffenhauer, A., Ertl, P., & Renner, S. (2011). Mining for Bioactive Scaffolds with Scaffold Networks: Improved Compound Set Enrichment from Primary Screening Data. Journal of Chemical Information and Modeling, 51(7), 1528-1538. https://doi.org/10.1021/ci2000924

Vellas, B., Coley, N., Ousset, P.-J., Berrut, G., Dartigues, J.-F., Dubois, B., Grandjean, H., Pasquier, F., Piette, F., Robert, P., Touchon, J., Garnier, P., Mathiex-Fortunet, H., & Andrieu, S. (2012). Long-term use of standardised Ginkgo biloba extract for the prevention of Alzheimer’s disease (GuidAge): a randomised placebo-controlled trial. Lancet Neurology, 11(10), 851-859. https://doi.org/10.1016/S1474-4422(12)70206-5

Visengeriyeva, L., Kammer, A., Bär, I., Kniesz, A., & Plöd, M. (2023). CRISP-ML(Q). The ML Lifecycle Process. INNOQ. https://ml-ops.org/content/crisp-ml

Wager, T. T., Hou, X., Verhoest, P. R., & Villalobos, A. (2010). Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties. ACS Chemical Neuroscience, 1(6), 435-449. https://doi.org/10.1021/cn100008c

Weininger, D. (1988). SMILES, a chemical language and information system. 1. Introduction to methodology and encoding rules. Journal of Chemical Information and Computer Sciences, 28(1), 31-36. https://doi.org/10.1021/ci00057a005

Weininger, D., Weininger, A., & Weininger, J. L. (1989). SMILES. 2. Algorithm for generation of unique SMILES notation. Journal of Chemical Information and Computer Sciences, 29(2), 97-101. https://doi.org/10.1021/ci00062a008

Wellawatte, G. P., Gandhi, H. A., Seshadri, A., & White, A. D. (2023). A Perspective on Explanations of Molecular Prediction Models. Journal of Chemical Theory and Computation, 19(8), 2149-2160. https://doi.org/10.1021/acs.jctc.2c01235

Wellawatte, G. P., Seshadri, A., & White, A. D. (2022). Model agnostic generation of counterfactual explanations for molecules. Chemical Science, 13(13), 3697-3705. https://doi.org/10.1039/D1SC05259D

Wiegreffe, S., & Pinter, Y. (2019). Attention is not not Explanation. Proceedings of EMNLP-IJCNLP 2019. https://aclanthology.org/D19-1002/

Wiener, H. (1947). Structural Determination of Paraffin Boiling Points. Journal of the American Chemical Society, 69(1), 17-20. https://doi.org/10.1021/ja01193a005

Wu, Z., Ramsundar, B., Feinberg, E. N., Gomes, J., Geniesse, C., Pappu, A. S., Leswing, K., & Pande, V. (2018). MoleculeNet: A Benchmark for Molecular Machine Learning. Chemical Science, 9(2), 513-530. https://doi.org/10.1039/C7SC02664A

Yang, K., Swanson, K., Jin, W., Coley, C., Eiden, P., Gao, H., Guzman-Perez, A., Hopper, T., Kelley, B., Mathea, M., Palmer, A., Settels, V., Jaakkola, T., Jensen, K., & Barzilay, R. (2019). Analyzing Learned Molecular Representations for Property Prediction. Journal of Chemical Information and Modeling, 59(8), 3370-3388. https://doi.org/10.1021/acs.jcim.9b00237

Yasir, M., Park, J., Han, E.-T., Park, W. S., Han, J.-H., Choe, J., & Chun, W. (2026). Machine Learning and Molecular Modeling Strategy for the Identification of CNS-Active Acetylcholinesterase Inhibitors. Pharmaceuticals, 19(7), 1120. https://doi.org/10.3390/ph19071120

Yasojima, K., Kuret, J., DeMaggio, A. J., McGeer, E., & McGeer, P. L. (2000). Casein kinase 1 delta mRNA is upregulated in Alzheimer disease brain. Brain Research, 865(1), 116-120. https://doi.org/10.1016/s0006-8993(00)02200-9

Ying, R., Bourgeois, D., You, J., Zitnik, M., & Leskovec, J. (2019). GNNExplainer: Generating Explanations for Graph Neural Networks. Advances in Neural Information Processing Systems 32 (NeurIPS 2019).

Yuan, Y., Zheng, F., & Zhan, C.-G. (2018). Improved Prediction of Blood-Brain Barrier Permeability Through Machine Learning with Combined Use of Molecular Property-Based Descriptors and Fingerprints. The AAPS Journal, 20(3), 54. https://doi.org/10.1208/s12248-018-0215-8

Yüksel, A., Ulusoy, E., Ünlü, A., & Doğan, T. (2023). SELFormer: Molecular Representation Learning via SELFIES Language Models. Machine Learning: Science and Technology, 4(2), 025035. https://doi.org/10.1088/2632-2153/acdb30

Zdrazil, B., Felix, E., Hunter, F., Manners, E. J., Blackshaw, J., Corbett, S., de Veij, M., Ioannidis, H., Lopez, D. M., Mosquera, J. F., Magarinos, M. P., Bosc, N., Arcila, R., Kizilören, T., Gaulton, A., Bento, A. P., Adasme, M. F., Monecke, P., Landrum, G. A., & Leach, A. R. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Research, 52(D1), D1180-D1192. https://doi.org/10.1093/nar/gkad1004

Zhang, Y., Zhou, Y., Xu, H., Jiang, W., Li, B., Lai, D., Wan, C., Wang, S., Zhao, M., Tan, Y., Lu, S., Fan, T., Liu, X., Zhu, F., & Chen, Y. (2026). Therapeutic target database 2026: facilitating targeted therapies and precision medicine. Nucleic Acids Research, 54(D1), D1692-D1701. https://doi.org/10.1093/nar/gkaf1154

Zhao, H., Yang, Y., Wang, S., Yang, X., Zhou, K., Xu, C., Zhang, X., Fan, J., Hou, D., Li, X., Lin, H., Tan, Y., Wang, S., Chu, X.-Y., Zhuoma, D., Zhang, F., Ju, D., Zeng, X., & Chen, Y. Z. (2023). NPASS database update 2023: quantitative natural product activity and species source database for biomedical research. Nucleic Acids Research, 51(D1), D621-D628. https://doi.org/10.1093/nar/gkac1069

Zhong, S., & Guan, X. (2023). Count-Based Morgan Fingerprint: A More Efficient and Interpretable Molecular Representation in Developing Machine Learning-Based Predictive Regression Models for Water Contaminants’ Activities and Properties. Environmental Science & Technology, 57(46), 18193-18202. https://doi.org/10.1021/acs.est.3c02198

Zhong, S., & Li, J. (2026). bit-collision-free-MF (paquete de PyPI).

Zhu, B., & Liu, S. (2025). Feature-Guided Machine Learning for Studying Passive Blood-Brain Barrier Permeability to Aid Drug Discovery. International Journal of Molecular Sciences, 26(22), 11228. https://doi.org/10.3390/ijms262211228

Zimprich, A., Biskup, S., Leitner, P., Lichtner, P., Farrer, M., Lincoln, S., Kachergus, J., Hulihan, M., Uitti, R. J., Calne, D. B., Stoessl, A. J., Pfeiffer, R. F., Patenge, N., Carbajal, I. C., Vieregge, P., Asmus, F., Müller-Myhsok, B., Dickson, D. W., Meitinger, T., … Gasser, T. (2004). Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron, 44(4), 601-607. https://doi.org/10.1016/j.neuron.2004.11.005